DE602006008339D1 - Zolpidemtabletten - Google Patents

Zolpidemtabletten

Info

Publication number
DE602006008339D1
DE602006008339D1 DE602006008339T DE602006008339T DE602006008339D1 DE 602006008339 D1 DE602006008339 D1 DE 602006008339D1 DE 602006008339 T DE602006008339 T DE 602006008339T DE 602006008339 T DE602006008339 T DE 602006008339T DE 602006008339 D1 DE602006008339 D1 DE 602006008339D1
Authority
DE
Germany
Prior art keywords
tablet
zolpidemtabletten
designed
dosage form
zolpidem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006008339T
Other languages
English (en)
Inventor
Dalen Frans Van
Korinde Annemarie Jansen
Farid Abedin Dorkoosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYNHTON BV
Original Assignee
SYNHTON BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYNHTON BV filed Critical SYNHTON BV
Publication of DE602006008339D1 publication Critical patent/DE602006008339D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
DE602006008339T 2005-11-18 2006-11-20 Zolpidemtabletten Active DE602006008339D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73781105P 2005-11-18 2005-11-18
PCT/EP2006/011131 WO2007065559A1 (en) 2005-11-18 2006-11-20 Zolpidem tablets

Publications (1)

Publication Number Publication Date
DE602006008339D1 true DE602006008339D1 (en) 2009-09-17

Family

ID=37714593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006008339T Active DE602006008339D1 (en) 2005-11-18 2006-11-20 Zolpidemtabletten

Country Status (8)

Country Link
US (1) US8148393B2 (de)
EP (1) EP1948132B1 (de)
KR (1) KR101345468B1 (de)
AT (1) ATE438381T1 (de)
AU (1) AU2006322314A1 (de)
CA (1) CA2629740A1 (de)
DE (1) DE602006008339D1 (de)
WO (1) WO2007065559A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR056633A1 (es) * 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
AU2013280644B2 (en) 2012-06-26 2018-08-02 Jeffrey A. BACHA Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or AHI1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
JP2016519684A (ja) 2013-04-08 2016-07-07 デニス エム ブラウン 準最適に投与された薬物療法の有効性を改善するための及び／又は副作用を低減するための方法および組成物
CN112472699A (zh) 2013-07-26 2021-03-12 种族肿瘤学公司 改善比生群及衍生物的治疗益处的组合方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3048526A (en) 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3388041A (en) 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
US3862140A (en) 1972-05-08 1975-01-21 Warner Lambert Co 4-hydroxy-2h- 1-benzothiopyran-3-carboxamide 1,1-dioxides
FR2492382A1 (fr) 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
US4626538A (en) 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
US4948592A (en) 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
FR2600650B1 (fr) 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
ATE123237T1 (de) 1990-08-24 1995-06-15 Spirig Ag Verfahren zur herstellung von pellets.
US5178867A (en) 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
IT1264696B1 (it) 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
GB9401894D0 (en) 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
IT1276522B1 (it) 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
US5773031A (en) 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
FR2772615B1 (fr) 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EP1005863A1 (de) * 1998-12-04 2000-06-07 Synthelabo Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
SI1038875T1 (en) 1999-03-25 2003-12-31 Synthon B.V. Imidazopyridine derivatives and process for making them
EP1064937A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
JP4637338B2 (ja) * 2000-09-22 2011-02-23 大塚製薬株式会社 シロスタゾール有核錠
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets

Also Published As

Publication number Publication date
KR101345468B1 (ko) 2013-12-30
AU2006322314A1 (en) 2007-06-14
WO2007065559A1 (en) 2007-06-14
ATE438381T1 (de) 2009-08-15
US8148393B2 (en) 2012-04-03
EP1948132B1 (de) 2009-08-05
EP1948132A1 (de) 2008-07-30
KR20080073342A (ko) 2008-08-08
CA2629740A1 (en) 2007-06-14
US20070166380A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
SG169353A1 (en) Tamper resistant dosage forms
TW201711676A (en) Ferric citrate dosage forms
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
FR2883179B1 (fr) Comprime enrobe
MX2007009162A (es) Formas de dosis rsistente al alcohol.
UA90875C2 (ru) Лекарственные формы пролонгированного действия, которые содержат ранолазин
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
BRPI0820997A2 (pt) Comprimidos de desintegração oral compreendendo difenidramina.
ZA200802272B (en) Novel dosage formulation
PL2079446T3 (pl) Preparat paliperidonu o przedłużonym uwalnianiu
GB0513984D0 (en) Dosage form
DK200900115U1 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
WO2007141743A3 (en) A tablet dosage form comprising cetirizine and pseudoephedrine
ZA200904654B (en) Tablet formulation
GB0424323D0 (en) Tablet
DE602006008339D1 (en) Zolpidemtabletten
GB0616794D0 (en) Solid dosage form
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
EP1915988A4 (de) Tablette mit mehreren arzneihaltigen segmenten
EP1867324A4 (de) Tablette
AU312575S (en) Craps table
EP2050456A4 (de) Tablette
CA119872S (en) Compressible container
UA27272U (en) Use of yakton as cardioprotector
UA27344U (en) Use of pollentar pharmaceutical composition as cerebroprotective agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition